EU Regulator To Re-Examine Safety Of Common Drugs

Law360 (September 26, 2006, 12:00 AM EDT) -- Europe’s top drug agency has launched another review of commonly used anti-inflammatory drugs amid concerns over a link to heightened risk of heart attacks.

The European Medicines Agency (EMA) said on Tuesday that it was launching a new review on non-selective non-steroidal anti-inflammatory drugs (NSAIDs), reversing an earlier stance that gave NSAIDs a clean bill of health.

EMA will present a scientific opinion next month to address the benefit-risk profile of the drugs, the agency said.

NSAIDs are widely used to treat arthritis and other painful...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.